Form 4: Hims & Hers Health CEO Andrew Dudum Sells 50,361 Shares

Andrew Dudum, CEO of Hims & Hers Health, sold 50,361 shares of Class A Common Stock on March 20, 2024, at an average price of $16.3431.

Summary

• On March 20, 2024, Andrew Dudum, the CEO of Hims & Hers Health, sold 50,361 shares of Class A Common Stock.
• The sale was executed at an average weighted price of $16.3431 per share, with individual sales prices ranging from $15.86 to $16.575.
• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on November 29, 2023.
• Following the transaction, Dudum continues to beneficially own a significant number of shares, both directly and indirectly through various trusts.
• The reported indirect ownership includes shares held by trustees of multiple trusts, including the Andrew Dudum 2015 Trust, several GRATs (Grantor Retained Annuity Trusts), the Dudum Family Community Property Trust, the Richard M. Dudum Irrevocable Trust, and the Dudum Family Heritage Trust.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an insider stock sale. It doesn't inherently convey positive or negative sentiment, as it simply reports a transaction.

Industry Context

Insider sales are a common occurrence, and the use of a 10b5-1 trading plan suggests the sale was pre-planned and not based on any specific non-public information.

Stakeholder Impact

• The stock sale could potentially create short-term selling pressure on the stock price, impacting shareholders.
• The sale itself has no direct impact on employees, customers, suppliers, or creditors.

Key Dates